{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:46:09Z","timestamp":1791103569416,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002019","name":"The Children's Fund for Glycogen Storage Disease Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002019","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ymgme.2013.06.014","type":"journal-article","created":{"date-parts":[[2013,6,25]],"date-time":"2013-06-25T13:54:46Z","timestamp":1372168486000},"page":"275-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia"],"prefix":"10.1016","volume":"110","author":[{"given":"Young Mok","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Jiunn","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Y.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.06.014_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1566524024605798","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex","volume":"2","author":"Chou","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type I and G6Pase-\u03b2 deficiency: etiology and therapy","volume":"6","author":"Chou","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM197602192940805","article-title":"Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease","volume":"294","author":"Greene","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM198401193100306","article-title":"Cornstarch therapy in type I glycogen storage disease","volume":"310","author":"Chen","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0025","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1517\/14712598.2011.578067","article-title":"Recombinant AAV-directed gene therapy for type I glycogen storage diseases","volume":"11","author":"Chou","year":"2011","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/mt.2008.15","article-title":"AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia","volume":"16","author":"Koeberl","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mt.2010.64","article-title":"Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy","volume":"18","author":"Yiu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0040","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.25717","article-title":"Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy","volume":"56","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2013.06.014_bb0045","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0050","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JVI.70.1.520-532.1996","article-title":"Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis","volume":"70","author":"Fisher","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0055","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type 1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0060","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/mt.2008.72","article-title":"Gene delivery to the juvenile mouse liver using AAV2\/8 vectors","volume":"16","author":"Cunningham","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00005176-199703000-00008","article-title":"Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature","volume":"24","author":"Labrune","year":"1997","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2013.06.014_bb0070","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-005-7500-2","article-title":"Hepatocellular carcinoma in glycogen storage disease type Ia: a case series","volume":"28","author":"Franco","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-2660(09)67002-4","article-title":"Adeno-associated viral vectors and their redirection to cell-type specific receptors","volume":"67","author":"Michelfelder","year":"2009","journal-title":"Adv. Genet."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0085","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0090","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/mt.2011.126","article-title":"Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector","volume":"19","author":"Luo","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abbi.1998.0849","article-title":"Ontogeny of the murine glucose-6-phosphatase system","volume":"358","author":"Pan","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0100","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1159\/000077378","article-title":"Successful gene transfer using adeno-associated virus vectors into the kidney: comparison among adeno-associated virus serotype 1\u20135 vectors in vitro and in vivo","volume":"96","author":"Takeda","year":"2004","journal-title":"Nephron Exp. Nephrol."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/mt.2010.250","article-title":"The complex and evolving story of T cell activation to AAV vector-encoded transgene products","volume":"19","author":"Mays","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nm1358","article-title":"Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response","volume":"12","author":"Manno","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0115","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2174\/156652307782151425","article-title":"Immune responses to AAV in clinical trials","volume":"7","author":"Mingozzi","year":"2007","journal-title":"Curr. Genet. Ther."},{"key":"10.1016\/j.ymgme.2013.06.014_bb0120","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/mt.2010.175","article-title":"Preexisting immunity and low expression in primates highlight translational challenges for liver-directed AAV8-mediated gene therapy","volume":"18","author":"Hurlbut","year":"2010","journal-title":"Mol. Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T02:39:08Z","timestamp":1595990348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213002163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S1096719213002163"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.06.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}